Study guide
6.2 Dosage Calculations, Unit Conversions & Pediatric/Geriatric Adjustments
Singapore Nursing Board SNB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Legal Framework & Regulatory Governing of Nursing in Singapore
1.1 Nurses and Midwives Act & SNB Regulatory Powers 1.2 Scope of Professional Nursing Practice & Accountability 1.3 Informed Consent, Confidentiality & PDPA in Healthcare
2 Chapter 2: Ethical Standards & Professional Code of Conduct
2.1 SNB Code for Nurses and Midwives & Ethical Principles 2.2 Patient Rights, Advocacy & End-of-Life Ethical Decision-Making 2.3 Safeguarding Vulnerable Patients & Mandatory Reporting
3 Chapter 3: Holistic Patient Assessment & Nursing Process
3.1 Comprehensive Physical Assessment & Vital Signs Monitoring 3.2 Early Warning Scores & Recognising the Deteriorating Patient 3.3 Nursing Diagnosis, Person-Centred Care Planning & Evaluation
4 Chapter 4: Communication, Documentation & Clinical Safety
4.1 Therapeutic Communication & Interpersonal Care Relationships 4.2 Clinical Documentation Standards & ISBAR Clinical Handover 4.3 Clinical Risk Management, Fall Prevention & Patient Safety Goals
5 Chapter 5: Infection Prevention & Control Standards
5.1 Standard & Transmission-Based Precautions (Infection Control) 5.2 Aseptic Technique, Surgical Hand Antisepsis & Wound Care Asepsis 5.3 Outbreak Management, Multi-Drug Resistant Organisms (MDROs) & Bio-waste
6 Chapter 6: Safe Medication Administration & Clinical Pharmacology
6.1 Rights of Medication Administration & High-Alert Medications 6.2 Dosage Calculations, Unit Conversions & Pediatric/Geriatric Adjustments 6.3 Pharmacokinetics, Adverse Drug Reactions & Poison Management 6.4 Medication Reconciliation, Storage & Controlled Substances Act in SG
7 Chapter 7: Intravenous Therapy, Fluid & Electrolyte Management
7.1 Fluid Balance, Electrolyte Disturbances & ABG Interpretation 7.2 Peripheral & Central Venous Line Access, Care & Complications 7.3 Blood Product Transfusion Standards, Safety & Adverse Reaction Management
8 Chapter 8: Respiratory Care & Oxygenation Management
8.1 Airway Management, Oxygen Therapy & Pulse Oximetry 8.2 Tracheostomy Care, Suctioning & Mechanical Ventilation Nursing 8.3 Nursing Care in Acute Respiratory Distress & Chronic Obstructive Pulmonary Disease
9 Chapter 9: Cardiovascular Nursing & Hemodynamic Monitoring
9.1 Cardiac Assessment, ECG Interpretation & Common Arrhythmias 9.2 Acute Coronary Syndrome, Heart Failure & Hypertensive Crises Nursing 9.3 Shock Classification, Fluid Resuscitation & Hemodynamic Monitoring
10 Chapter 10: Medical-Surgical Nursing: Gastrointestinal & Renal Systems
10.1 Enteral & Parenteral Nutrition Management 10.2 Care of Acute Abdomen, Ostomy Care & Gastrointestinal Bleeding 10.3 Acute Kidney Injury, Chronic Kidney Disease & Dialysis Nursing
11 Chapter 11: Endocrine & Metabolic Nursing Management
11.1 Diabetes Mellitus: Glycemic Control, Insulin Therapy & Complications 11.2 Management of Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.3 Thyroid, Adrenal & Pituitary Endocrine Disorders
12 Chapter 12: Neurological Nursing & Musculoskeletal Care
12.1 Neurological Assessment, Glasgow Coma Scale (GCS) & Stroke Care 12.2 Increased Intracranial Pressure (ICP) & Seizure Management 12.3 Musculoskeletal Assessment, Traction, Cast Care & Mobility Promotion
13 Chapter 13: Perioperative & Wound Management
13.1 Preoperative Assessment, Preparation & Informed Consent Verification 13.2 Intraoperative Standards, Surgical Time-Out & Anesthesia Monitoring 13.3 Postoperative Recovery, Pain Management & Wound Healing Staging
14 Chapter 14: Elder Care, Gerontological Nursing & Chronic Disease
14.1 Comprehensive Geriatric Assessment & Frailty Syndromes 14.2 Dementia, Delirium & Depression in Older Adults 14.3 Pressure Injury Prevention, Staging & Advanced Wound Dressings
15 Chapter 15: Mental Health Nursing & Psychosocial Care
15.1 Mental Health Assessment & Therapeutic Nurse-Patient Engagement 15.2 Mood Disorders, Psychosis & Crisis Intervention 15.3 Mental Health Act in Singapore, De-escalation & Patient Safety
16 Chapter 16: Palliative Care & Symptom Management
16.1 Principles of Palliative & End-of-Life Nursing Care 16.2 Pain Assessment, Opioid Titration & Breakthrough Pain Management 16.3 Advance Care Planning (ACP) & Care of the Dying Patient
17 Chapter 17: Interprofessional Collaboration & Care Coordination
17.1 Transdisciplinary Team Dynamics & Multidisciplinary Case Conferences 17.2 Care Coordination, Community Discharge Planning & Continuity of Care 17.3 Conflict Resolution & Interprofessional Communication
18 Chapter 18: Delegation, Supervision & Clinical Leadership
18.1 Principles of Delegation to Enrolled Nurses (ENs) & Ancillary Staff 18.2 Clinical Supervision, Resource Management & Ward Operations 18.3 Quality Improvement, Clinical Audit & Incident Reporting
19 Chapter 19: Evidence-Based Practice, Education & Professional Growth
19.1 Reflective Practice & SNB CPE (Continuing Professional Education) Requirements 19.2 Integrating Evidence-Based Practice (EBP) into Clinical Care 19.3 Clinical Education, Student Preceptorship & Mentorship
6.2 Dosage Calculations, Unit Conversions & Pediatric/Geriatric Adjustments
Key Takeaways Explain This Topic AI
Dosage calculations must utilize standardized dimensional analysis or formula methods ( D / H × V = X D/H \times V = X D / H × V = X ) with zero tolerance for trailing zeros (e.g., 5 mg 5\text{ mg} 5 mg , NOT 5.0 mg 5.0\text{ mg} 5.0 mg ) and mandatory leading zeros (e.g., 0.5 mg 0.5\text{ mg} 0.5 mg , NOT .5 mg .5\text{ mg} .5 mg ).
Intravenous drop rates ( gtt/min \text{gtt/min} gtt/min ) rely on drop factor calibration: gtt/min = ( Volume in mL × Drop Factor in gtt/mL ) / Time in minutes \text{gtt/min} = (\text{Volume in mL} \times \text{Drop Factor in gtt/mL}) / \text{Time in minutes} gtt/min = ( Volume in mL × Drop Factor in gtt/mL ) / Time in minutes .
Pediatric dosing in Singapore relies strictly on weight-based calculations ( mg/kg/dose \text{mg/kg/dose} mg/kg/dose or mg/kg/day \text{mg/kg/day} mg/kg/day ) or Body Surface Area ( BSA in m 2 = [ height (cm) × weight (kg) ] / 3600 \text{BSA in m}^2 = \sqrt{[\text{height (cm)} \times \text{weight (kg)}] / 3600} BSA in m 2 = [ height (cm) × weight (kg) ] /3600 ).
Geriatric dosage adjustments require calculating Creatinine Clearance via the Cockcroft-Gault formula to account for age-related declines in renal Glomerular Filtration Rate (GFR).
Reconstitution calculations must factor in powder displacement volume to ensure precise final concentration delivery.
Last updated: July 2026
6.2 Dosage Calculations, Unit Conversions & Pediatric/Geriatric Adjustments
Accurate clinical calculation is an absolute prerequisite for medication safety. A single decimal point error can result in a 10-fold ( 1000 % 1000\% 1000% ) overdose or underdose, leading to severe toxicity or therapeutic failure. Registered nurses in Singapore must master unit conversions, oral and parenteral dose formulas, intravenous flow rates, powder reconstitutions, and specialized pediatric and geriatric adjustments.
Core Metric Conversions & Safe Writing Practices
Clinical calculations in Singapore public health institutions strictly adhere to the International System of Units (SI). Nurses must seamlessly convert between metric mass and volume units:
Mass : 1 gram (g) = 1 , 000 milligrams (mg) = 1 , 000 , 000 micrograms (mcg) 1\text{ gram (g)} = 1,000\text{ milligrams (mg)} = 1,000,000\text{ micrograms (mcg)} 1 gram (g) = 1 , 000 milligrams (mg) = 1 , 000 , 000 micrograms (mcg)
Volume : 1 liter (L) = 1 , 000 milliliters (mL) 1\text{ liter (L)} = 1,000\text{ milliliters (mL)} 1 liter (L) = 1 , 000 milliliters (mL)
Safe Writing Rules (ISMP & MOH Directives):
NEVER use trailing zeros : Write 5 mg 5\text{ mg} 5 mg , NEVER 5.0 mg 5.0\text{ mg} 5.0 mg (misreading 5.0 5.0 5.0 as 50 mg 50\text{ mg} 50 mg is a major error source).
ALWAYS use leading zeros : Write 0.25 mg 0.25\text{ mg} 0.25 mg , NEVER .25 mg .25\text{ mg} .25 mg (misreading .25 .25 .25 as 25 mg 25\text{ mg} 25 mg causes a 100-fold overdose).
Use standardized microgram abbreviations : Write mcg \text{mcg} mcg , NEVER μ g \mu\text{g} μ g (which can be confused with mg \text{mg} mg in handwritten notes).
Fundamental Dosage Formulas
1. Desired over Have Formula: Amount to Administer ( X ) = Desired Dose ( D ) Hand/Available Dose ( H ) × Vehicle Volume ( V ) \text{Amount to Administer } (X) = \frac{\text{Desired Dose } (D)}{\text{Hand/Available Dose } (H)} \times \text{Vehicle Volume } (V) Amount to Administer ( X ) = Hand/Available Dose ( H ) Desired Dose ( D ) × Vehicle Volume ( V )
Example : Order: Digoxin 125 mcg 125\text{ mcg} 125 mcg PO daily. Available: Digoxin oral solution 0.05 mg/mL 0.05\text{ mg/mL} 0.05 mg/mL .
Convert units to match: 125 mcg = 0.125 mg 125\text{ mcg} = 0.125\text{ mg} 125 mcg = 0.125 mg .
Calculate: X = ( 0.125 mg / 0.05 mg ) × 1 mL = 2.5 mL X = (0.125\text{ mg} / 0.05\text{ mg}) \times 1\text{ mL} = 2.5\text{ mL} X = ( 0.125 mg /0.05 mg ) × 1 mL = 2.5 mL .
2. Intravenous Flow Rate Calculations:
Volumetric Pump Rate (mL/hr) : Pump Rate (mL/hr) = Total Volume to Infuse (mL) Total Time (hours) \text{Pump Rate (mL/hr)} = \frac{\text{Total Volume to Infuse (mL)}}{\text{Total Time (hours)}} Pump Rate (mL/hr) = Total Time (hours) Total Volume to Infuse (mL)
Gravity Manual Drip Rate (gtt/min) : Drip Rate (gtt/min) = Total Volume (mL) × Drop Factor (gtt/mL) Time (minutes) \text{Drip Rate (gtt/min)} = \frac{\text{Total Volume (mL)} \times \text{Drop Factor (gtt/mL)}}{\text{Time (minutes)}} Drip Rate (gtt/min) = Time (minutes) Total Volume (mL) × Drop Factor (gtt/mL)
Common Drop Factors in SG Hospitals :
Macrodrip Sets : 10 gtt/mL , 15 gtt/mL , 20 gtt/mL 10\text{ gtt/mL}, 15\text{ gtt/mL}, 20\text{ gtt/mL} 10 gtt/mL , 15 gtt/mL , 20 gtt/mL (standard adult blood/fluid tubing).
Microdrip Sets : 60 gtt/mL 60\text{ gtt/mL} 60 gtt/mL (pediatric, neonatal, and ICU precision tubing).
Powder Reconstitution & Volume Displacement
When reconstituting powdered medications (e.g., IV Ampicillin, Ceftriaxone, Hydrocortisone), nurses must calculate the final drug concentration by accounting for powder displacement volume : Final Volume = Volume of Diluent Added + Powder Displacement Volume \text{Final Volume} = \text{Volume of Diluent Added} + \text{Powder Displacement Volume} Final Volume = Volume of Diluent Added + Powder Displacement Volume Final Concentration = Total Solute Mass Final Volume \text{Final Concentration} = \frac{\text{Total Solute Mass}}{\text{Final Volume}} Final Concentration = Final Volume Total Solute Mass
Clinical Example : A vial contains 1 g ( 1 , 000 mg ) 1\text{ g} (1,000\text{ mg}) 1 g ( 1 , 000 mg ) of powdered Ceftriaxone. The package insert states that adding 9.6 mL 9.6\text{ mL} 9.6 mL of Sterile Water for Injection yields a final volume of 10.0 mL 10.0\text{ mL} 10.0 mL (powder displaces 0.4 mL 0.4\text{ mL} 0.4 mL ). The final concentration is 1 , 000 mg / 10 mL = 100 mg/mL 1,000\text{ mg} / 10\text{ mL} = 100\text{ mg/mL} 1 , 000 mg /10 mL = 100 mg/mL . To administer a prescribed dose of 750 mg 750\text{ mg} 750 mg , the nurse draws up: ( 750 mg / 100 mg/mL ) = 7.5 mL (750\text{ mg} / 100\text{ mg/mL}) = 7.5\text{ mL} ( 750 mg /100 mg/mL ) = 7.5 mL .
Pediatric Dosing Adjustments & Body Surface Area (BSA)
Children possess immature hepatic enzyme systems, underdeveloped renal clearance, and variable fluid balance, making weight-based and BSA-based dosing essential.
1. Weight-Based Dosing (mg/kg):
Always calculate the daily or per-dose allowance in mg/kg \text{mg/kg} mg/kg and cross-reference with maximum adult single doses.
Example : A pediatric patient weighing 14 kg 14\text{ kg} 14 kg is prescribed Paracetamol 15 mg/kg/dose 15\text{ mg/kg/dose} 15 mg/kg/dose PO. Syrup concentration is 120 mg / 5 mL 120\text{ mg} / 5\text{ mL} 120 mg /5 mL .
Calculate target dose: 14 kg × 15 mg/kg = 210 mg 14\text{ kg} \times 15\text{ mg/kg} = 210\text{ mg} 14 kg × 15 mg/kg = 210 mg .
Calculate volume: ( 210 mg / 120 mg ) × 5 mL = 8.75 mL (210\text{ mg} / 120\text{ mg}) \times 5\text{ mL} = 8.75\text{ mL} ( 210 mg /120 mg ) × 5 mL = 8.75 mL .
2. Body Surface Area (BSA) Formula (Most Accurate for Cytotoxic / Chemotherapy Agents): BSA (m 2 ) = Height (cm) × Weight (kg) 3600 \text{BSA (m}^2) = \sqrt{\frac{\text{Height (cm)} \times \text{Weight (kg)}}{3600}} BSA (m 2 ) = 3600 Height (cm) × Weight (kg) Pediatric Dose = Child’s BSA (m 2 ) × Standard Adult Dose per m 2 \text{Pediatric Dose} = \text{Child's BSA (m}^2) \times \text{Standard Adult Dose per m}^2 Pediatric Dose = Child’s BSA (m 2 ) × Standard Adult Dose per m 2
Geriatric Pharmacokinetics & Renal Clearance Adjustments
Age-related physiological changes alter drug handling significantly in elderly patients ( > 65 > 65 > 65 years):
Physiological Change Pharmacokinetic Consequence Clinical / Nursing Action
Decreased Glomerular Filtration Rate (GFR) Prolonged clearance of renally excreted drugs (digoxin, gentamicin, enoxaparin, metformin). Monitor serum creatinine and calculate Cockcroft-Gault Creatinine Clearance (CrCl) .
Decreased Hepatic Blood Flow & CYP450 Reduced first-pass clearance; elevated serum drug concentrations. Administer lower initial doses ("start low and go slow").
Decreased Serum Albumin Reduced protein binding; increased free active drug fraction (e.g., warfarin, phenytoin). Monitor free drug levels; observe for early toxicity signs.
Increased Body Fat % & Decreased Body Water Lipophilic drugs (diazepam) have prolonged half-life; hydrophilic drugs (digoxin) have smaller V d V_d V d . Adjust loading doses and dosing intervals.
Cockcroft-Gault Equation for Creatinine Clearance (CrCl): CrCl (mL/min) = ( 140 − Age ) × Weight (kg) 72 × Serum Creatinine (mg/dL) × ( 0.85 if female ) \text{CrCl (mL/min)} = \frac{(140 - \text{Age}) \times \text{Weight (kg)}}{72 \times \text{Serum Creatinine (mg/dL)}} \times (0.85 \text{ if female}) CrCl (mL/min) = 72 × Serum Creatinine (mg/dL) ( 140 − Age ) × Weight (kg) × ( 0.85 if female )